Medtech Regulation In Latin America: Why Harmonization Matters
This article was originally published in Clinica
What do the Latin American countries of Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela have in common when it comes to the regulation of medical devices and IVDs? How do they differ in their approaches? And how is the regulatory scene changing in these countries? Christian Lopez-Silva and Henrique Frizzo of Baker McKenzie address these questions and provide a useful overview to guide regulatory decision-making in this region
You may also be interested in...
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.
Canada has announced new restrictions on exports to help mitigate the impact of measures in the US to lower medicine prices there.
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.